Jeffrey N. Simmons - Mar 1, 2023 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
PRESIDENT, CEO AND DIRECTOR, Director
Signature
/s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons
Stock symbol
ELAN
Transactions as of
Mar 1, 2023
Transactions value $
-$243,305
Form type
4
Date filed
3/3/2023, 08:10 PM
Previous filing
Sep 9, 2022
Next filing
Mar 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Tax liability -$143K -12.7K -1.68% $11.26 742K Mar 1, 2023 Direct F1, F2
transaction ELAN Common Stock Award $0 +249K +33.5% $0.00 991K Mar 1, 2023 Direct F3
transaction ELAN Common Stock Tax liability -$101K -9.15K -0.93% $11.01 975K Mar 2, 2023 Direct F1, F4
holding ELAN Common Stock 30K Mar 1, 2023 Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +568K $0.00 568K Mar 1, 2023 Common Stock 568K $11.26 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F2 Includes 2,045 shares acquired under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022.
F3 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.
F4 Balance reflects 7,127 fewer shares due to an error in the number of shares previously reported as forfeited in a prior Form 4.
F5 Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026.